FSMEX quote
23.29up +0.23 +1.00%
Previous Close23.06CategoryHealth
Net Assets1.13 BilDividend Yield0.02%
Morningstar ratings:Minimum Initial Purchase2,500
RiskAverage1 Year Return45.07%
RatingRating: 5 out of 53 Year Return4.00%
ReturnHigh5 Year Return6.17%
Cumulative growth of a $10,000 investment
10k growth chart
20042005200620072008YTD
Growth17.48%26.26%31.40%54.88%18.66%50.00%
Value$11,748$12,626$13,140$15,488$11,866$15,000
Last NAV update 11/23/2009 8:00 PM ET   Financial data in U.S. dollars

Your latest quotes:  USB, CA:BBD.A, CHA, CHS, HOTT, FSMEX

Overview
The investment seeks capital appreciation. The fund normally invests at least 80% of assets in securities of companies principally engaged in research, development, manufacture, distribution, supply, or sale of medical equipment and devices and related technologies. It may invest in securities of foreign issuers and may invest a significant percentage of assets in a single issuer. The fund is nondiversified.
More information for FSMEX
Fees and expenses
Front load0.00%
Deferred load0.00%
Expense Ratio0.87%
Top holdings for FSMEX
Company Name% Net Assets
Covidien, Ltd.13.20%
Baxter International Inc.9.87%
Medtronic, Inc.7.28%
Boston Scientific, Inc.6.24%
C.R. Bard, Inc.4.99%
More top holdings for FSMEX
Additional Fund Information
Inception date04/28/1998
ManagerEdward Yoon
Manager start date05/01/2007


Page generated 7:29 AM Eastern Time